PDGFRB and Hepatic fibrosis: There is sufficient evidence now that HSCs are the main cellular target for the treatment of liver fibrosis, and the dysregulated PDGF-B/PDGFR-β signaling pathway is an important inducement for the pathological transdifferentiation of HSCs and crucial pathological factor for liver fibrosis9,15,16.